| Country |
Population |
Age(N) |
Criteria |
MS Prevalence
(% of the population) |
| Men |
Women |
Total |
| France |
Men and Women |
35-64
(3359) |
NCEP |
3,0 |
16,9 |
- |
| France |
Men |
50-59
(10 592) |
NCEP
IDF
WHO |
29,7
38,9
35,5 |
-
-
- |
-
-
- |
| Germany |
Men and Women |
(4816 men and 2315 women) |
NCEP |
23,5 |
17,6 |
- |
| Holland |
Adult men and women |
50-75
(1364) |
NCEP
WHO |
19,0
26,0 |
32,0
26,0 |
-
- |
| Italy |
Men and Women |
45-64
(1877) |
NCEP |
24,1 |
23,1 |
22,2 |
| Italy |
Men and Women |
40-79
(888) |
NCEP
WHO |
-
- |
-
- |
17,8
34,1 |
| Italy |
Men and Women |
≥19
(2100) |
NCEP |
15,0 |
18,0 |
- |
| Italy |
Men and Women |
65-84
(5632) |
NCEP |
29,9* |
55,2* |
- |
| Spain |
Men and Women |
35-64
(2540) |
NCEP
IDF |
27,7 |
33,6 |
- |
| Portugal |
Men and Women |
18-90
(1436) |
NCEP |
19,1 |
21,0 |
23,9 |
| Greece |
Men and Women |
Adults
(9669) |
NCEP
IDF |
-
- |
-
- |
24,5
43,4 |
| Croatia |
Men and Women |
18-88
(996) |
NCEP |
- |
- |
34,0 |
| United Kingdom |
Men and Women |
60-79
(3589) |
NCEP
IDF
WHO |
-
-
- |
29,8
47,5
20,9 |
- |
NCEP = US National Cholesterol Education Program - Adult Treatment Panel III; IDF = International Diabetes Federation;
WHO = World Health Organization. *Subgroup with diabetes, 64.9% of the men and 87.1% of the women have Metabolic Syndrome according to NCEP |
